Nanohmics to Test Hyperspectral Imager on ISS - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Nanohmics to Test Hyperspectral Imager on ISS

    Article obtained from Photonics RSS Feed.

    Nanohmics Inc., in collaboration with the University of Maryland and the NASA Langley Research Center, will send a prototype compact hyperspectral imager to the International Space Station (ISS) where it will be tested for calibration. The launch will take place in 2021.

    The device is considerably smaller and lighter than existing spectral imaging satellites. The prototype, developed by Nanohmics and the University of Maryland, images over the visible range of the electromagnetic spectrum. Incident light reaching each pixel on the microchip is scattered into wavelength-dependent patterns, where special algorithms are applied to calculate the spectrum through computational spectroscopy. The hyperspectral imager was successfully flown…

    READ MORE
    Oct, 27 2020 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.